Minghui Pharmaceutical (Shanghai) LTD clinical trials
A subsidiary of Minghui Pharmaceutical
The registry lists 2 studies whose lead sponsor is Minghui Pharmaceutical (Shanghai) LTD. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 10, 2026.
- 2studies on the registry
- 1open to participants now
What changed recently
From the registry's own updates since Oct 15, 2026.
Newly registered1
- A Clinical Study of MHB034C for Injection in Participants With Advanced Solid TumorsNov 10, 2026NCT07928570
All 2 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Open now150%
- Status unknown or other150%
Over the years
- 121
- 22
- 23
- 24
- 25
- 126
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Minghui Pharmaceutical (Shanghai) LTD2 studies
Something wrong with this grouping? Tell us on the Minghui Pharmaceutical page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Minghui Pharmaceutical studies →
- A Clinical Study of MHB034C for Injection in Participants With Advanced Solid TumorsNot yet recruitingNCT07928570Phase 1/2
Sponsor listed in the registry: Minghui Pharmaceutical (Shanghai) LTD
- This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell MalignanciesStatus unknownNCT04689308Phase 1
Sponsor listed in the registry: Minghui Pharmaceutical (Shanghai) LTD